Consolidated companies as of December 31, 2019 (Tables)

12 Months Ended

Dec. 31, 2019

Consolidated companies as of December 31, 2019

Disclosure of voting rights in consolidated companies


				Year ended December 31,
				2019				2018		2017
Name of the subsidiary		Country		% voting right Galapagos NV (directly or indirectly through subsidiaries)		Change in % voting right previous period (2019 vs 2018)		% voting right Galapagos NV (directly or indirectly through subsidiaries)		% voting right Galapagos NV (directly or indirectly through subsidiaries)

BioFocus DPI AG in liquidation		Switzerland		100%				100%		100%
Galapagos Biopharma Belgium BV		Belgium		100%		100%
Galapagos Biopharma Netherlands B.V.		The Netherlands		100%		100%
Galapagos Biopharma Spain S.L.U		Spain		100%		100%
Galapagos Biopharma Italy S.r.l.		Italy		100%		100%
Galapagos Biopharma Germany GmbH		Germany		100%		100%
Galapagos B.V.		The Netherlands		100%				100%		100%
Galapagos Biotech Ltd. (formerly Inpharmatica Ltd.)		United Kingdom		100%				100%		100%
Galapagos GmbH		Switzerland		100%				100%		100%
Galapagos, Inc. (formerly Biofocus, Inc.)		United States		100%				100%		100%
Galapagos NV		Belgium		Parent company				Parent company		Parent company
Galapagos Real Estate 1 BV		Belgium		100%				100%
Galapagos Real Estate 2 BV		Belgium		100%				100%
Galapagos Real Estate Netherlands B.V.		The Netherlands		100%		100%
Galapagos SASU		France		100%				100%		100%
Fidelta d.o.o.		Croatia		100%				100%		100%
Xenometrix, Inc. in liquidation		United States		100%				100%		100%